ICD-10-CM Codes
C00-D49 Neoplasms
D3A-D3A Benign neuroendocrine tumors
D3A- Benign neuroendocrine tumors

2019 ICD-10-CM Diagnosis Code D3A.8

Other benign neuroendocrine tumors

2016

2017

2018

2019

Billable/Specific Code

D3A.8 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2019 edition of ICD-10-CM D3A.8 became effective on October 1, 2018.
This is the American ICD-10-CM version of D3A.8 - other international versions of ICD-10 D3A.8 may differ.

Applicable To

Neuroendocrine tumor NOS

The following code(s) above D3A.8 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

Applicable To annotations, or
Code Also annotations, or
Code First annotations, or
Excludes1 annotations, or
Excludes2 annotations, or
Includes annotations, or
Note annotations, or
Use Additional annotations

that may be applicable to D3A.8:

C00-D49
2019 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Neoplasms
D3A
ICD-10-CM Diagnosis Code D3A
Benign neuroendocrine tumors
Code Also
- any associated multiple endocrine neoplasia [MEN] syndromes (E31.2-)
Type 2 Excludes
- benign pancreatic islet cell tumors (D13.7)
Use Additional
- code to identify any associated endocrine syndrome, such as:
- carcinoid syndrome (E34.0)
Benign neuroendocrine tumors

Approximate Synonyms

Benign adenoma of middle ear
Benign neuroendocrine adenoma of middle ear
Benign neuroendocrine tumor bronchus
Benign neuroendocrine tumor large intestine
Benign neuroendocrine tumor lung
Benign neuroendocrine tumor of appendix
Benign neuroendocrine tumor of ascending colon
Benign neuroendocrine tumor of bilateral kidneys
Benign neuroendocrine tumor of bronchus
Benign neuroendocrine tumor of cecum
Benign neuroendocrine tumor of descending colon
Benign neuroendocrine tumor of duodenum
Benign neuroendocrine tumor of ileum
Benign neuroendocrine tumor of jejunum
Benign neuroendocrine tumor of large intestine
Benign neuroendocrine tumor of left kidney
Benign neuroendocrine tumor of liver
Benign neuroendocrine tumor of lung
Benign neuroendocrine tumor of pancreas
Benign neuroendocrine tumor of rectum
Benign neuroendocrine tumor of right kidney
Benign neuroendocrine tumor of sigmoid colon
Benign neuroendocrine tumor of small intestine
Benign neuroendocrine tumor of stomach
Benign neuroendocrine tumor of thymus
Benign neuroendocrine tumor of transverse colon
Benign neuroendocrine tumor stomach
Benign neuroendocrine tumor thymus
Benign neuroendocrine tumor, appendix
Benign neuroendocrine tumor, ascending colon
Benign neuroendocrine tumor, bilateral kidneys
Benign neuroendocrine tumor, cecum
Benign neuroendocrine tumor, descending colon
Benign neuroendocrine tumor, duodenum
Benign neuroendocrine tumor, ileum
Benign neuroendocrine tumor, jejunum
Benign neuroendocrine tumor, liver
Benign neuroendocrine tumor, pancreas
Benign neuroendocrine tumor, rectum
Benign neuroendocrine tumor, sigmoid colon
Benign neuroendocrine tumor, small intestine
Benign neuroendocrine tumor, transverse colon

Clinical Information

A benign or malignant neoplasm composed of cells of neuroendocrine origin. Representative examples include paraganglioma, carcinoid tumor, and neuroendocrine carcinoma.
A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established.
A tumor that forms from cells that release hormones in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinomas, pheochromocytomas, and neuroendocrine carcinomas of the skin (merkel cell cancer). These tumors may secrete higher-than-normal amounts of hormones, which can cause many different symptoms.
Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via apud cells), the presence of tumor-associated antigens, and isozyme composition.

ICD-10-CM D3A.8 is grouped within Diagnostic Related Group(s) (MS-DRG v36.0):

826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with mcc
827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure with cc
828 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedure without cc/mcc
829 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure with cc/mcc
830 Myeloproliferative disorders or poorly differentiated neoplasms with other procedure without cc/mcc
843 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with mcc
844 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses with cc
845 Other myeloproliferative disorders or poorly differentiated neoplastic diagnoses without cc/mcc

Convert D3A.8 to ICD-9-CM

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change

Diagnosis Index entries containing back-references to D3A.8:

Tumor - see also Neoplasm, unspecified behavior, by site
- neuroendocrine D3A.8

ICD-10-CM Codes Adjacent To D3A.8

D3A.029 Benign carcinoid tumor of the large intestine, unspecified portion

D3A.09 Benign carcinoid tumors of other sites

D3A.090 Benign carcinoid tumor of the bronchus and lung

D3A.091 Benign carcinoid tumor of the thymus

D3A.092 Benign carcinoid tumor of the stomach

D3A.093 Benign carcinoid tumor of the kidney

D3A.094 Benign carcinoid tumor of the foregut, unspecified

D3A.095 Benign carcinoid tumor of the midgut, unspecified

D3A.096 Benign carcinoid tumor of the hindgut, unspecified

D3A.098 Benign carcinoid tumors of other sites

D3A.8 Other benign neuroendocrine tumors

D37 Neoplasm of uncertain behavior of oral cavity and digestive organs

D37.0 Neoplasm of uncertain behavior of lip, oral cavity and pharynx

D37.01 Neoplasm of uncertain behavior of lip

D37.02 Neoplasm of uncertain behavior of tongue

D37.03 Neoplasm of uncertain behavior of the major salivary glands

D37.030 Neoplasm of uncertain behavior of the parotid salivary glands

D37.031 Neoplasm of uncertain behavior of the sublingual salivary glands

D37.032 Neoplasm of uncertain behavior of the submandibular salivary glands

D37.039 …… unspecified

D37.04 Neoplasm of uncertain behavior of the minor salivary glands

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

2019 ICD-10-CM Diagnosis Code D3A.8

Other benign neuroendocrine tumors

Neoplasms

Benign neuroendocrine tumors